Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen

A distinct neurogenomic response to a trade-off between social challenge and opportunity in male sticklebacks (Gasterosteus aculeatus).

Biology letters·2023

Targeting improved resilience in Merino sheep - Correlations between immune competence and health and fitness traits.

Animal : an international journal of animal bioscience·2022

Determination of secretory granule maturation times in pancreatic islet β-cells by serial block-face electron microscopy.

Journal of structural biology·2020

A standardized method for quantifying consistent individual differences in schooling behaviour.

Journal of fish biology·2016

Combining quantitative 2D and 3D image analysis in the serial block face SEM: application to secretory organelles of pancreatic islet cells.

Journal of microscopy·2015

Quantitative analysis of mouse pancreatic islet architecture by serial block-face SEM.

Journal of structural biology·2014

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

BTK Inhibitor Ibrutinib Reduces Bispecific Antibody-Related CRS Without Undermining the Anti-Tumor Efficacy.

Cancer science·2026

Ikaros degradation by Iberdomide correlates with normalization of cytokines in Th cells of patients with systemic lupus erythematosus.

Journal of immunology (Baltimore, Md. : 1950)·2026

The Place of Therapeutic Apheresis in Severe Immune-Related Adverse Events: A Scoping Review of Literature.

Journal of clinical apheresis·2026

[Nontuberculous mycobacterial infections in patients with hematologic diseases].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[The role of MAGIC biomarkers in acute GVHD].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

[Current treatment strategies for diffuse large B-cell lymphoma].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026

Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen

Related Experiment Videos

Related Concept Videos

A distinct neurogenomic response to a trade-off between social challenge and opportunity in male sticklebacks (Gasterosteus aculeatus).

Targeting improved resilience in Merino sheep - Correlations between immune competence and health and fitness traits.

Determination of secretory granule maturation times in pancreatic islet β-cells by serial block-face electron microscopy.

A standardized method for quantifying consistent individual differences in schooling behaviour.

Combining quantitative 2D and 3D image analysis in the serial block face SEM: application to secretory organelles of pancreatic islet cells.

Quantitative analysis of mouse pancreatic islet architecture by serial block-face SEM.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

BTK Inhibitor Ibrutinib Reduces Bispecific Antibody-Related CRS Without Undermining the Anti-Tumor Efficacy.

Ikaros degradation by Iberdomide correlates with normalization of cytokines in Th cells of patients with systemic lupus erythematosus.

The Place of Therapeutic Apheresis in Severe Immune-Related Adverse Events: A Scoping Review of Literature.

[Nontuberculous mycobacterial infections in patients with hematologic diseases].

[The role of MAGIC biomarkers in acute GVHD].

[Current treatment strategies for diffuse large B-cell lymphoma].

Detection of antibodies to islet cells and insulin with paraffin-embedded pancreas as antigen

Related Experiment Videos

Related Concept Videos

Related Articles